Cargando…

Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), recognized as the liver manifestation of metabolic syndrome, is highly prevalent in the general population. Recent studies suggest that lipid accumulation product is significantly associated with metabolic abnormalities. The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Haijiang, Wang, Weijun, Chen, Ruifang, Chen, Zhiheng, Lu, Yao, Yuan, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539973/ https://www.ncbi.nlm.nih.gov/pubmed/28775758 http://dx.doi.org/10.1186/s12986-017-0206-2

Ejemplares similares

Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study
por: Dai, Haijiang, et al.
Publicado: (2016)

The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults
por: Li, Hejun, et al.
Publicado: (2022)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Acacetin Protects against Non-Alcoholic Fatty Liver Disease by Regulating Lipid Accumulation and Inflammation in Mice
por: Liou, Chian-Jiun, et al.
Publicado: (2022)

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
por: Cheng, Yuan-Lung, et al.
Publicado: (2017)

Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2012)

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
por: Geng, Yana, et al.
Publicado: (2021)

Association of lipid accumulation product trajectories with 5-year incidence of type 2 diabetes in Chinese adults: a cohort study
por: Yan, Guangyu, et al.
Publicado: (2019)

Aqueous Extract of Pepino (Solanum muriactum Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic Fatty Liver Disease
por: Hsu, Jen-Ying, et al.
Publicado: (2018)

Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity
por: Özcabı, Bahar, et al.
Publicado: (2019)

Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults
por: Liu, Yiting, et al.
Publicado: (2022)

Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
por: Zhang, Shengkui, et al.
Publicado: (2022)

Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease
por: Sun, Xulong, et al.
Publicado: (2020)

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
por: Li, Yunjia, et al.
Publicado: (2022)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

Lingonberry Improves Non-Alcoholic Fatty Liver Disease by Reducing Hepatic Lipid Accumulation, Oxidative Stress and Inflammatory Response
por: Madduma Hewage, Susara, et al.
Publicado: (2021)

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
por: Kawano, Yuki, et al.
Publicado: (2013)

Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice
por: Liu, Zhen-Shu, et al.
Publicado: (2022)

Comparison of lipid accumulation product and body mass index as indicators of diabetes diagnosis among 215,651 Chinese adults
por: Tian, Tian, et al.
Publicado: (2020)

Distinct developmental trajectories of body mass index and diabetes risk: A 5‐year longitudinal study of Chinese adults
por: Dai, Haijiang, et al.
Publicado: (2019)

Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
por: Zhao, Ruifang, et al.
Publicado: (2020)

LncRNA-AK012226 Is Involved in Fat Accumulation in db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model
por: Chen, Xingtian, et al.
Publicado: (2018)

Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice
por: Lei, Shan-Shan, et al.
Publicado: (2021)

A Novel Indicator Of Lipid Accumulation Product Associated With Metabolic Syndrome In Chinese Children And Adolescents
por: Zhang, Yifei, et al.
Publicado: (2019)

The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression
por: Vecchione, Giulia, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population
por: Chen, Yi, et al.
Publicado: (2021)

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
por: Zhang, Lijia, et al.
Publicado: (2022)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
por: Liu, Qing, et al.
Publicado: (2010)

Hydrogen sulphide in liver glucose/lipid metabolism and non‐alcoholic fatty liver disease
por: Mateus, Inês, et al.
Publicado: (2021)

LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
por: Lee, Jibeom, et al.
Publicado: (2023)

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients
por: Yao, Jinmei, et al.
Publicado: (2014)

Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitro
por: Chienwichai, Peerut, et al.
Publicado: (2019)

Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro
por: Hwangbo, Hyun, et al.
Publicado: (2020)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
por: Ebrahimi, Menooa, et al.
Publicado: (2023)

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
por: Yang, Jia-Min, et al.
Publicado: (2019)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_crh0sdlhqtjkok42us6egu96g8